Only management can be held responsible for the lack of performance from our share price. We should all know by now management will not say a word about partnerships until the deal is done, this lack of communication is the normal when communicating with your share holders.
We have had a 20-25% uplift from the BH partnership, an extra 23 million in the bank, a share price that has held up above 40 cents, with out next quarter to show profits from the sales of Striate+, Im not expecting 20 million per quarter, or per year, more like 3-6 million per 100 thousand products sold. Sure this could ramp up over the next few years and we could sell half a million annually, this cash is supplying a good foundation for other pipelines to reach approvals, TGA, FDA move products to phase 3 of trials and eventually through to partnership
I like many, have waited eight years of nothing to reach this stage, let’s hope management can turn a corner and get new, bigger financial interest in this company, otherwise we are going to be lucky to top out at 50 cents.
Good luck to all and let’s hope our share price starts to trade where it belongs,
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)